|
Indian pharma stocks fell up to 3% after U.S. President Trump announced a 25% tariff on Indian imports over its trade with Russia. Concerns rose about potential inclusion of generic drugs in the tariff list. Analysts expect strategic shifts by exporters and a cautious, range-bound market reaction.
Category:
News and Media
Adrian Mowat suggests Indian markets can quickly absorb a 25% tariff impact, though it might weaken the rupee and limit the RBI's flexibility. He highlights the geopolitical motivations behind potential US penalties on India and China's oil imports from Russia. This situation could negatively affect foreign investment inflows into India due to a less favorable risk-reward scenario.
Category:
News and Media
Punjab National Bank's shares dipped 4% following a 48% YoY drop in net profit for Q1 2025, reporting Rs 1,675 crore against last year's Rs 3,251.5 crore, impacted by a significant tax expense. While total income rose 15.7%, NII saw marginal growth. Asset quality improved with reduced GNPA and NNPA.
Category:
News and Media
All news |
||||||||||||||||||
|